Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
C
Caito, Samuel
Husson University
(
T1030-01-02
)
Blueberry-Derived Exosomes as a Natural miRNA Delivery System for the Treatment of Neurodegenerative Diseases
Samuel Caito
Favorite
Caldwell, Jenna
AstraZeneca
(
T1030-02-07
)
Viscosity Reduction of an IgG1 Antibody via Hydrogen-Deuterium Exchange Mass Spectrometry-Augmented Protein Engineering
Jenna Caldwell
Favorite
Campbell, Joey
Prolytix
(
T1430-02-07
)
Advancements in Free Heme Analysis: Utilizing a Co-Solvent to Simplify Sample Preparation
Joey Campbell
Favorite
Campellone, Shalyn
Pfizer Inc.
(
M1130-02-07
)
Embracing Singlicate Ligand Binding Biomarker Assays: A Case Study Comparing Duplicate vs Singlicate Analysis for the Determination of IL-6, IFN-gamma, and TNF-alpha in Human Sodium Heparin Plasma
Shalyn Campellone
Favorite
Canham, Spencer
Husson University
(
T1030-01-02
)
Blueberry-Derived Exosomes as a Natural miRNA Delivery System for the Treatment of Neurodegenerative Diseases
Spencer Canham
Favorite
Cao, April
Western Canada High School
(
M1230-01-01
)
Generating Novel Linker Sequences in Antibody-Drug Conjugates with Diffusion Models
April Cao
Favorite
Cao, Yu
Merck & Co., Inc.
(
T1130-02-06
)
Using Tasso-M20 Microsampling Device to Support a Clinical PK Study
Yu Cao
Favorite
Cataldi, Vince
Oregon State University
(
M1330-01-05
)
Mitigation of Doxorubicin-Induced Cardiotoxicity and Chemosensitization Using Combination Phytochemicals in Polymeric Micelles
Vince Cataldi
Favorite
Chakraborty, Samrat
Oregon State University
(
M1330-01-05
)
Mitigation of Doxorubicin-Induced Cardiotoxicity and Chemosensitization Using Combination Phytochemicals in Polymeric Micelles
Samrat Chakraborty
Favorite
Chakravarty, Amrit
KCAS Bio
(
M1530-02-09
)
Development of a High Throughput LC-MS/MS 1.5 Plex Assay for Quantitation of Total Antibody (TAb) and Intact Antibody Drug Conjugate (ADC) Using Immunoprecipitation by Specific Receptor Capture
Amrit Chakravarty
Favorite
Chak, Vincent
University at Buffalo
(
M1430-02-08
)
Structural Modifications of Phosphatidylserine and Their Impact on Oral Tolerance
Vincent Chak
Favorite
Challa, Ranadheer Reddy
Quotient Sciences
(
T1230-01-01
)
Mutagenic NDSRI of Citalopram - Critical Structural Evaluation of Carcinogenic Category and Development of a Highly Sensitive LC-MS/MS Method Development for Quantification
Ranadheer Reddy Challa
Favorite
Chang, Irene
Merck & Co., Inc.
(
M1330-01-01
)
Utility of Small Angle X-Ray Scattering (SAXS) in Process Development, Characterization and Comparability of Lipid Nanoparticles, Liposomes and Fusion Proteins
Irene Chang
Favorite
Chaudhary, Ankit
Saraswati Institute of Pharmaceutical Sciences
(
M1130-02-06
)
Anti-Urolithiatic and Diuretic Activities of Ethyl Acetate Fraction of
Grewia flavescens
Roots
Ankit Chaudhary
Favorite
Cheng, Eric
Genentech, Inc.
(
M1030-02-07
)
Pharmacokinetic/Pharmacodynamic Insights into VSIG4 Degrading Antibodies
Eric Cheng
Favorite
Chen, Jake
University of Alabama at Birmingham
(
M1230-01-01
)
Generating Novel Linker Sequences in Antibody-Drug Conjugates with Diffusion Models
Jake Chen
Favorite
Chen, Quanmin
WuXi Biologics
(
T1230-01-03
)
Break Loose Force and Glide Force Evaluation of Various Container Closure System Combination for Empty Syringe
Quanmin Chen
Favorite
Chen, Wei
WuXi Biologics
(
T1430-01-02
)
Insights from Drug Development Experts: Surveying Challenges and Outcomes for Large-Volume Subcutaneous Oncology Drugs
Wei Chen
Favorite
Chen, Yundi
Binghamton University
(
T1430-01-05
)
Rapid and Precise Detection of Mutations in Extracellular Vesicle DNA Using a Liposome-Based CRISPR-Cas12a System
Yundi Chen
Favorite
Chiu, Mark
Tavotek Biotherapeutics
(
M1430-02-06
)
Clinical Evidence of Safety, Prolonged Half-Life, and Low Immunogenicity of Monoclonal Antibodies TAVO101 and TAVO103 Engineered with Multiple Fc Mutations
Mark Chiu
Favorite
(
T1330-02-09
)
Preliminary Phase 1a Clinical Results of Multispecific Antibody TAVO412 in Patients with Hard-to-Treat Solid Tumors
Mark Chiu
Favorite
Cho, Hea-Young
CHA University
(
T1330-02-08
)
First-in-Human Dose Optimization of Enavogliflozin Eye Drops via Population PBPK Modeling for Treatment of Diabetic Retinopathy
Hea-Young Cho
Favorite
Cho, Hyunjin
ChungNam National University
(
M0930-02-09
)
Comprehensive Pharmacokinetic Profiling of C004019: A PROTAC Targeting Tau Protein in Neurodegenerative Disorders
Hyunjin Cho
Favorite
(
M1430-02-07
)
Assessment of Antibody-Drug Conjugate Stability in Mouse Skin Homogenate Supernatant Using Liquid Chromatographic-Quadrupole Time-of-Flight Mass Spectrometric Method
Hyunjin Cho
Favorite
(
M1430-02-09
)
Application of Sequential Window Acquisition of all Theoretical Fragment Ion Spectra Mass Spectrometry (SWATH-MS) for Identification of Tetrapeptide Linker Cleavage Profile of Antibody Drug Conjugate
Hyunjin Cho
Favorite
(
M1530-02-07
)
Simultaneous Analysis of Antibody-Conjugated Drug(acDrug) and Total Antibody(tAb) for Antibody Drug Conjugate Using Dual Enzyme-Assisted Sample Preparation Followed by LC-MS
Hyunjin Cho
Favorite
Choi, Doyoung
SCIEX
(
M1230-02-06
)
Application of icIEF-UV/MS for Rapid Proteoform Characterization and Charge Variant Analysis of a Novel Antibody-Drug Conjugate in Drug Discovery
Doyoung Choi
Favorite
(
M1530-02-08
)
Charge Variant Profiling of Antibody-Drug Conjugate Containing Auristatins Using icIEF-UV-MS
Doyoung Choi
Favorite
Choi, Go-Wun
CHA University
(
T1330-02-08
)
First-in-Human Dose Optimization of Enavogliflozin Eye Drops via Population PBPK Modeling for Treatment of Diabetic Retinopathy
Go-Wun Choi
Favorite
Cho, Jong Un
TriOar Inc.
(
M1230-02-06
)
Application of icIEF-UV/MS for Rapid Proteoform Characterization and Charge Variant Analysis of a Novel Antibody-Drug Conjugate in Drug Discovery
Jong Un Cho
Favorite
(
M1530-02-08
)
Charge Variant Profiling of Antibody-Drug Conjugate Containing Auristatins Using icIEF-UV-MS
Jong Un Cho
Favorite
Cho, Seok-Jin
CHA University
(
T1330-02-08
)
First-in-Human Dose Optimization of Enavogliflozin Eye Drops via Population PBPK Modeling for Treatment of Diabetic Retinopathy
Seok-Jin Cho
Favorite
Christian, Twinkle
Amgen
(
T1430-01-02
)
Insights from Drug Development Experts: Surveying Challenges and Outcomes for Large-Volume Subcutaneous Oncology Drugs
Twinkle Christian
Favorite
Chuh, Josefa
Genentech, Inc.
(
M1030-02-07
)
Pharmacokinetic/Pharmacodynamic Insights into VSIG4 Degrading Antibodies
Josefa Chuh
Favorite
Clegg, Benjamin
Duquesne University
(
T0930-01-04
)
Zinc-Associated Peptide Coacervates for Recombinant Protein Capture and Release
Benjamin Clegg
Favorite
Clements, Brianna
Waters Corporation
(
M1030-01-01
)
Development of Improved Chromatographic Methods for the Separation of Synthetic Peptide Medications and Associated Impurities
Brianna Clements
Favorite
Coble, Kelly
Boehringer Ingelheim
(
T1030-02-08
)
Systematic Optimization of ADA Assays for Complex Biologics: A Framework for Addressing Assay Challenges Across Modalities
Kelly Coble
Favorite
Connor, Robert
Halozyme Therapeutics, Inc.
(
T0930-01-05
)
Preclinical Subcutaneous Injectability and Local Tolerability of an Antibody-Drug Conjugate Delivered with Recombinant Human Hyaluronidase PH20 Using a Handheld High-Volume Auto-Injector
Robert Connor
Favorite
Craig, Kelly
Merck & Co., Inc.
(
T1130-02-06
)
Using Tasso-M20 Microsampling Device to Support a Clinical PK Study
Kelly Craig
Favorite
Crane, Grant
University of Georgia
(
T1230-01-04
)
Application of Experimentally Derived Hansen Solubility Parameters to Optimize Amorphous Solid Dispersion Formulation
Grant Crane
Favorite
Crouse, Tyler
Eurofins Viracor BioPharma Services
(
M1230-02-08
)
Comprehensive AAV-Based Vector Shedding Assessment by PCR: A Case Study with Whole Blood, Serum, Semen, Urine, and Buccal Swab
Tyler Crouse
Favorite
Cruz, Eric
Celerion
(
M1530-02-06
)
Improving Drug Tolerance in Anti-Drug Antibody (ADA) Assay using PandA Method – Case Studies
Eric Cruz
Favorite
